Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

5alpha-reductase inhibitors dampen L-DOPA-induced dyskinesia via normalization of dopamine D1-receptor signaling pathway and D1-D3 receptor interaction
Silvia Fanni, Simona Scheggi, Francesca Rossi, et al.
Neurobiology of Disease (2018) Vol. 121, pp. 120-130
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Dopamine, Immunity, and Disease
Breana Channer, Stephanie Matt, Emily Nickoloff-Bybel, et al.
Pharmacological Reviews (2022) Vol. 75, Iss. 1, pp. 62-158
Open Access | Times Cited: 149
Dopamine D3 receptor: A neglected participant in Parkinson Disease pathogenesis and treatment?
Pengfei Yang, Joel S. Perlmutter, Tammie L.S. Benzinger, et al.
Ageing Research Reviews (2019) Vol. 57, pp. 100994-100994
Open Access | Times Cited: 73
Sex differences in steroid levels and steroidogenesis in the nervous system: Physiopathological role
Silvia Giatti, Silvia Diviccaro, Melania Maria Serafini, et al.
Frontiers in Neuroendocrinology (2019) Vol. 56, pp. 100804-100804
Open Access | Times Cited: 51
Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats
Chang-Qing Zheng, Hongxia Fan, Xiaoxian Li, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 24
Neurosteroid influence on affective tone
Najah Walton, Pantelis Antonoudiou, Jamie Maguire
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105327-105327
Open Access | Times Cited: 9
Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
Silvia Giatti, Silvia Diviccaro, Eva Falvo, et al.
Frontiers in Neuroendocrinology (2020) Vol. 57, pp. 100836-100836
Open Access | Times Cited: 27
Pregnenolone for the treatment of L-DOPA-induced dyskinesia in Parkinson's disease
Sara Corsi, Simona Scheggi, Alessandra Pardu, et al.
Experimental Neurology (2023) Vol. 363, pp. 114370-114370
Open Access | Times Cited: 8
Neurosteroids: A novel promise for the treatment of stroke and post‐stroke complications
Jiawei Xu, Yunxiang Zhou, Caochong Yan, et al.
Journal of Neurochemistry (2021) Vol. 160, Iss. 1, pp. 113-127
Open Access | Times Cited: 18
IRL790 modulated striatal D1 neurons synaptic plasticity ameliorating levodopa-induced dyskinesia in mouse
Xiaofei Wang, Wangming Zhang
Frontiers in Aging Neuroscience (2024) Vol. 16
Open Access | Times Cited: 2
Expanding the therapeutic potential of neuro(active)steroids: a promising strategy for hyperdopaminergic behavioral phenotypes
Simona Scheggi, Luca Concas, Sara Corsi, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 164, pp. 105842-105842
Open Access | Times Cited: 2
The p75 neurotrophin receptor as a novel intermediate in L-dopa-induced dyskinesia in experimental Parkinson's disease
Zhihua Liu, Aijuan Yan, Jiahao Zhao, et al.
Experimental Neurology (2021) Vol. 342, pp. 113740-113740
Closed Access | Times Cited: 16
Allopregnanolone: The missing link to explain the effects of stress on tic exacerbation?
Marco Bortolato, Barbara J. Coffey, Vilma Gabbay, et al.
Journal of Neuroendocrinology (2021) Vol. 34, Iss. 2
Open Access | Times Cited: 16
Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia
Kathryn Lanza, Ashley Centner, Michael Coyle, et al.
Experimental Neurology (2020) Vol. 336, pp. 113534-113534
Closed Access | Times Cited: 16
Dopamine D1 + D3 receptor density may correlate with parkinson disease clinical features
Pengfei Yang, William C. Knight, Huifangjie Li, et al.
Annals of Clinical and Translational Neurology (2020) Vol. 8, Iss. 1, pp. 224-237
Open Access | Times Cited: 16
Effect of sex and gonadectomy on brain MPTP toxicity and response to dutasteride treatment in mice
Amandine Isenbrandt, Marc Morissette, Mélanie Bourque, et al.
Neuropharmacology (2021) Vol. 201, pp. 108784-108784
Closed Access | Times Cited: 15
Androgens and Parkinson's Disease: A Review of Human Studies and Animal Models
Mélanie Bourque, Denis Soulet, Thérèse Di Paolo
Androgens Clinical Research and Therapeutics (2021) Vol. 2, Iss. 1, pp. 294-303
Open Access | Times Cited: 15
BDNF Overexpression Increases Striatal D3 Receptor Level at Striatal Neurons and Exacerbates D1-Receptor Agonist-Induced Dyskinesia
Simona Scheggi, Francesca Rossi, Sara Corsi, et al.
Journal of Parkinson s Disease (2020) Vol. 10, Iss. 4, pp. 1503-1514
Closed Access | Times Cited: 13
Allopregnanolone and its antagonist modulate neuroinflammation and neurological impairment
Torbjörn Bäckström, Magnus Doverskog, Thomas P. Blackburn, et al.
Neuroscience & Biobehavioral Reviews (2024) Vol. 161, pp. 105668-105668
Open Access | Times Cited: 1
Dopamine D3 Receptor Plasticity in Parkinson’s Disease and L-DOPA-Induced Dyskinesia
Kathryn Lanza, Christopher Bishop
Biomedicines (2021) Vol. 9, Iss. 3, pp. 314-314
Open Access | Times Cited: 10
Carnosic Acid Alleviates Levodopa-Induced Dyskinesia and Cell Death in 6-Hydroxydopamine-lesioned Rats and in SH-SY5Y Cells
Chun-Yi Lai, Chia‐Yuan Lin, Chi‐Rei Wu, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 10
Reciprocal cross-sensitization of D1 and D3 receptors following pharmacological stimulation in the hemiparkinsonian rat
Kathryn Lanza, Katherine Chemakin, Sarah Lefkowitz, et al.
Psychopharmacology (2019) Vol. 237, Iss. 1, pp. 155-165
Closed Access | Times Cited: 9
New insights into pathogenesis of l-DOPA-induced dyskinesia
Chang-Qing Zheng, Feng Zhang
NeuroToxicology (2021) Vol. 86, pp. 104-113
Closed Access | Times Cited: 8
The steroidogenic inhibitor finasteride reverses pramipexole-induced alterations in probability discounting
Gabriele Floris, Simona Scheggi, Romina Pes, et al.
Brain Research Bulletin (2022) Vol. 181, pp. 157-166
Open Access | Times Cited: 5
Neuroactive steroids and Parkinson's disease
Mélanie Bourque, Thérèse Di Paolo
Current Opinion in Endocrine and Metabolic Research (2021) Vol. 22, pp. 100312-100312
Closed Access | Times Cited: 7
G Protein-Dependent Activation of the PKA-Erk1/2 Pathway by the Striatal Dopamine D1/D3 Receptor Heteromer Involves Beta-Arrestin and the Tyrosine Phosphatase Shp-2
Federica Bono, Zaira Tomasoni, Veronica Mutti, et al.
Biomolecules (2023) Vol. 13, Iss. 3, pp. 473-473
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top